Berkovic S F, Andermann F, Andermann E, Carpenter S, Wolfe L
Department of Neurology and Neurosurgery, McGill University, Montreal, Quebec, Canada.
Am J Med Genet Suppl. 1988;5:105-9. doi: 10.1002/ajmg.1320310614.
In patients with an acceptable pathological diagnosis of Kufs disease, two major forms have been identified: Type A presenting as progressive myoclonus epilepsy around the age of 30, and Type B presenting in the same age range with dementia as well as cerebellar and/or extra-pyramidal signs. In adolescence, two subgroups of neuronal ceroid-lipofuscinosis (NCL) emerge. The first group consists of patients resembling either type A or B Kufs disease, but with earlier onset (20% of all cases). These must be distinguished from the second group of rare patients with protracted juvenile NCL presenting with early and prominent visual failure. Although Kufs disease is rare, diagnosis during life should now be possible. The advantages, techniques, and pitfalls of biopsy diagnosis are presented by Carpenter et al. [1988]. We believe that delineation of these two clinical syndromes should aid in the identification of other possible cases of Kufs disease, leading to appropriate pathological examinations to confirm the diagnosis. Knowledge of whether this clinical distinction is biologically meaningful must await the discovery of the more fundamental biochemical defects.
在库夫斯病病理诊断可接受的患者中,已确定两种主要类型:A型在30岁左右表现为进行性肌阵挛癫痫,B型在相同年龄范围表现为痴呆以及小脑和/或锥体外系体征。在青少年期,出现了两个神经元蜡样脂褐质沉积症(NCL)亚组。第一组患者类似于A型或B型库夫斯病,但起病较早(占所有病例的20%)。必须将这些患者与第二组罕见的持续性青少年NCL患者区分开来,后者表现为早期且明显的视力减退。尽管库夫斯病罕见,但现在应该可以在生前做出诊断。卡彭特等人[1988年]介绍了活检诊断的优点、技术和陷阱。我们认为,明确这两种临床综合征应有助于识别库夫斯病的其他可能病例,从而进行适当的病理检查以确诊。这种临床区分在生物学上是否有意义,必须等待发现更基本的生化缺陷。